At the heart of the Oncopole of Toulouse, the CRCT, together with all its partners (institutional, academic, clinical, industrial, charities…), stimulates innovation in terms of research and teaching in the fight against cancer.
The CRCT is a joint Research Unit Inserm & University Toulouse III Paul Sabatier
3 research teams are also labelled by the CNRS
Researchers, clinicians and supports
PhD students and post-doctoral fellows
Three major stakeholders of the Oncopole form a strategic public-private sector alliance to boost innovation in oncology on the Toulouse campus
A multi-year framework agreement has just been signed by 3 major stakeholders present on the Oncopole campus in Toulouse: the Pierre Fabre Research Institute (IRPF), the Centre de Recherches en Cancérologie de Toulouse (CRCT-Inserm) and the Institut Universitaire du...
Prof. Hervé Avet-Loiseau, head of the "Myeloma Genomics" unit at IUCT-Oncopole and the "Oncogenomics and immunology of myeloma" team at CRCT is on Clarivate Analytics' list of the most influential researchers of the past decade. This is a prestigious recognition of...
IMLINFO is a cross-border network of personalized immunotherapies for Non-Hodgkin's lymphomas (NHL) involving 7 organizations located in Spain and France. Its main objective is to determine the efficacy of new immunotherapy treatments through the creation of a NHL...
- February 1 @ 08:00 - February 5 @ 17:00
- January 28 @ 08:30 - 16:45 at Auditorium Marthe Condat Université Paul Sabatier
Conférence CRCT : Dr Christopher Pin / University of Western Ontario – Cell stress and epigenetic reprogramming in pancreatic cancerJanuary 24 @ 11:00 - 12:00 at Salle C. Cazaux, CRCT
2 avenue Hubert Curien
31037 TOULOUSE CEDEX 1 – FRANCE